Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 12 results

Author Title Type [ Year

]

Filters: Author is Anderson, Evan J [Clear All Filters]

2020

Maner-Smith, Kristal M, Johannes B Goll, Manoj Khadka, Travis L Jensen, Jennifer K Colucci, Casey E Gelber, Carolyn J Albert, et al.. 2020. “Alterations In The Human Plasma Lipidome In Response To Tularemia Vaccination.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030414. https://pubmed.ncbi.nlm.nih.gov/32722213/.

Lai, Lilin, Nadine Rouphael, Yongxian Xu, Amy C Sherman, Srilatha Edupuganti, Evan J Anderson, Pamela Lankford-Turner, et al.. 2020. “Baseline Levels Of Influenza-Specific B Cells And T Cell Responses Modulate Human Immune Responses To Swine Variant Influenza A/h3N2 Vaccine.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010126.

Lai, Lilin, Kevin Ault, Nadine Rouphael, Allison Beck, Briyana Domjahn, Yongxian Xu, Evan J Anderson, et al.. 2020. “Duration Of Cellular And Humoral Responses After Quadrivalent Human Papillomavirus Vaccination In Healthy Female Adults With Or Without Prior Type 16 And/or 18 Exposure.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030348.

Jackson, Lisa A, Evan J Anderson, Nadine G Rouphael, Paul C Roberts, Mamodikoe Makhene, Rhea N Coler, Michele P McCullough, et al.. 2020. “An Mrna Vaccine Against Sars-Cov-2 - Preliminary Report.”. N Engl J Med. N Engl J Med. doi:10.1056/NEJMoa2022483.

Anderson, Evan J, Lilin Lai, Jens Wrammert, Sarah Kabbani, Yongxian Xu, Lalita Priyamvada, Heather Hill, et al.. 2020. “Plasmablast, Memory B Cell, Cd4+ T Cell, And Circulating Follicular Helper T Cell Responses To A Non-Replicating Modified Vaccinia Ankara Vaccine.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010069.

Anderson, Evan J, Nadine G Rouphael, Alicia T Widge, Lisa A Jackson, Paul C Roberts, Mamodikoe Makhene, James D Chappell, et al.. 2020. “Safety And Immunogenicity Of Sars-Cov-2 Mrna-1273 Vaccine In Older Adults.”. N Engl J Med. N Engl J Med. doi:10.1056/NEJMoa2028436. https://pubmed.ncbi.nlm.nih.gov/32991794/.

Goll, Johannes B, Shuzhao Li, James L Edwards, Steven E Bosinger, Travis L Jensen, Yating Wang, William F Hooper, et al.. 2020. “Transcriptomic And Metabolic Responses To A Live-Attenuated Vaccine.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030412. https://pubmed.ncbi.nlm.nih.gov/32722194/.

2019

Kotloff, Karen L, Debbie-Ann T Shirley, Buddy C Creech, Sharon E Frey, Christopher J Harrison, Mary Staat, Evan J Anderson, et al.. 2019. “Mupirocin For Decolonization Of Infants In Neonatal Intensive Care Units.”. Pediatrics 143 (1). Pediatrics. doi:10.1542/peds.2018-1565.

Rouphael, Nadine G, Selwyn J Hurwitz, Mari Hart, Allison Beck, Evan J Anderson, Gregory Deye, Blaire Osborn, et al.. 2019. “Phase Ib Trial To Evaluate The Safety And Pharmacokinetics Of Multiple Ascending Doses Of Filociclovir (Mbx-400, Cyclopropavir) In Healthy Volunteers.”. Antimicrob Agents Chemother 63 (9). Antimicrob Agents Chemother. doi:10.1128/AAC.00717-19.

Munoz, Flor M, Evan J Anderson, David I Bernstein, Christopher J Harrison, Barbara Pahud, Edwin Anderson, Buddy C Creech, et al.. 2019. “Safety And Immunogenicity Of Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2V) Vaccine In Children And Adolescents.”. Vaccine 37 (36). Vaccine: 5161-5170. doi:10.1016/j.vaccine.2019.07.085.

Natrajan, Muktha S, Nadine Rouphael, Lilin Lai, Dmitri Kazmin, Travis L Jensen, David S Weiss, Chris Ibegbu, et al.. 2019. “Systems Vaccinology For A Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral And Cellular Immune Responses.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010004.

2017

Jackson, Lisa A, Sharon E Frey, Hana MEl Sahly, Mark J Mulligan, Patricia L Winokur, Karen L Kotloff, James D Campbell, et al.. 2017. “Safety And Immunogenicity Of A Modified Vaccinia Ankara Vaccine Using Three Immunization Schedules And Two Modes Of Delivery: A Randomized Clinical Non-Inferiority Trial.”. Vaccine 35 (13). Vaccine: 1675-1682. doi:10.1016/j.vaccine.2017.02.032.